Home › Products › Rheumatology › Orencia Powder for infusion
Orencia Powder for infusion
Salt Composition: ABATACEPT
- Manufacturer: BRISTOL MYERS SQUIBB
- Pack Size: 1 VIAL(s)
- Dosage Form: INJECTION
- Prescription Required
- Storage: Store at 2°C to 8°C (refrigerated). Do not freeze. Keep the powder vial upright in its original packaging. Protect from light. Once reconstituted, it should be used within the recommended timeframe based on aseptic handling guidelines.
₹28000.00₹30000.00
Inclusive of all taxes
Product Introduction
Orencia Powder for Infusion contains Abatacept, an immunomodulatory biologic medicine used to treat autoimmune inflammatory conditions including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and juvenile idiopathic arthritis (JIA). These conditions develop when the immune system mistakenly attacks healthy joints and tissues, causing pain, swelling, stiffness, and progressive joint damage. Abatacept is a selective T-cell co-stimulation modulator that reduces abnormal immune activation driving chronic inflammation. It is typically prescribed when conventional treatments such as methotrexate or other disease-modifying antirheumatic drugs (DMARDs) have proved ineffective. This medicine is administered via intravenous infusion under medical supervision. Orencia is contraindicated in patients with known hypersensitivity to Abatacept or any excipient. Before initiating therapy, assessment for active infections, chronic lung conditions, and vaccination status is necessary.
Uses
Rheumatoid Arthritis (RA): Reduces joint inflammation, slows disease progression, and improves daily functioning. Psoriatic Arthritis (PsA): Helps reduce joint pain, swelling, and skin-related inflammation. Juvenile Idiopathic Arthritis (JIA): Used in children aged 2 years and older with moderate to severe disease.
How it works
Abatacept targets a key pathway involved in immune activation: T-cells require two signals to become activated. Abatacept blocks the second signal (co-stimulation) by binding to CD80/86 on antigen-presenting cells. This prevents full activation of T-cells. Without activation, T-cells cannot trigger the inflammatory cascade contributing to autoimmune joint damage. Result: Reduced inflammation, decreased joint swelling, better mobility, and slowed long-term structural damage. Orencia does not suppress the immune system entirely; it selectively modulates dysfunction, making it a targeted therapy for inflammatory arthritis.
Side Effects
Serious Side Effects: Severe infections (pneumonia, TB reactivation) Infusion reactions (breathing difficulty, chest tightness) Allergic reactions (swelling, rash, hives) Increased risk of malignancies (rare) Common Side Effects: Headache Dizziness Nausea High blood pressure Cough or respiratory infections Fatigue Injection/infusion-site reactions Joint pain or worsening arthritis symptoms during initial doses Seek medical care immediately if you experience persistent fever, shortness of breath, or unusual bruising.
References
- Bristol-Myers Squibb. Orencia (Abatacept) Prescribing Information https://packageinserts.bms.com/pi/pi_orencia.pdf
- Schiff M. et al. (2008). Abatacept for rheumatoid arthritis treatment outcomes. Annals of Rheumatic Diseases https://ard.bmj.com/content/67/4/498
- American College of Rheumatology (ACR) Guidelines on Biologic DMARDs https://rheumatology.org/clinical-practice-guidelines
Safety Advice
Pregnancy: Consult Your Doctor Consult your doctor. Limited data is available. It should be used only when the benefits justify the potential risks.
Lungs: Consult Your Doctor No major adjustments are needed, but always inform your doctor about lung conditions.
Breastfeeding: Consult Your Doctor Consult your doctor. Abatacept may pass into breast milk; breastfeeding may need to be temporarily paused.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.